In this study, in order to further confirm that overexpressed AQP9 may inhibit the progression in HCC by suppressing Wnt/β-catenin signaling, SKL2001 was used to activate Wnt/β-catenin pathway in HCC cells following the transfection with LV-AQP9. This evidence concerns the gene AQP9 and hepatocellular carcinoma.